• Air Traffic Control
  • Annual Highway Report
  • Open Enrollment
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Chief Economist
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President, Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Government Financial Project
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy

Drug Policy

  • Ibogaine
  • Industrial Hemp
  • Marijuana Regulations
  • Medical Marijuana
  • Opioid Crisis
  • Psychedelics

  • How Trump’s executive order could accelerate widespread access to psychedelic therapies
    How Trump’s executive order could accelerate widespread access to psychedelic therapies

    Commentary by Leonard Gilroy and Geoffrey Lawrence

  • Tennessee bills would eliminate the state’s legal kratom market 
    Tennessee bills would eliminate the state’s legal kratom market 

    Commentary by Sephria Reynolds-Tanner

  • Colorado becomes the first state to address wrongful arrests and convictions caused by unreliable field drug tests
    Colorado becomes the first state to address wrongful arrests and convictions caused by unreliable field drug tests

    Commentary by Vittorio Nastasi and David L. Morgan

  • Why isn’t the Food and Drug Administration celebrating the decline in youth tobacco use?
    Why isn’t the Food and Drug Administration celebrating the decline in youth tobacco use?

    Commentary by Guy Bentley

  • Separating fact from fear in drug-related child welfare policy
    Separating fact from fear in drug-related child welfare policy

    Commentary by Layal Bou Harfouch and Hanna Liebman Dershowitz

  • Model legislation for audit requirements for opioid settlement fund recipients
    Model legislation for audit requirements for opioid settlement fund recipients

    Commentary by Geoffrey Lawrence, Mariana Trujillo and Layal Bou Harfouch

  • States should prioritize private service providers for the opioid settlement funds
    States should prioritize private service providers for the opioid settlement funds

    Commentary by Layal Bou Harfouch, Mariana Trujillo and Adrian Moore

  • Mississippi and West Virginia to join Texas ibogaine initiative 
    Mississippi and West Virginia to join Texas ibogaine initiative 

    Commentary by Geoffrey Lawrence

  • South Carolina Senate Bill 519 would establish a lower excise tax rate for heated tobacco products 
    South Carolina Senate Bill 519 would establish a lower excise tax rate for heated tobacco products 

    Testimony by Guy Bentley

More Drug Policy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 59
  • Next

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2026 Reason Foundation